Minireview: Dynamic Structures of Nuclear Hormone Receptors: New Promises and Challenges
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Therapeutic targeting of nuclear receptors (NRs) is presently restricted due to 2 constraints: 1) a limited knowledge of the structural dynamics of intact receptor when complexed to DNA and coregulatory proteins; and 2) the inability to more selectively modulate NR actions at specific organ/gene targets. A major obstacle has been the current lack of understanding about the function and structure of the intrinsically disordered N-terminal domain that contains a major regulatory transcriptional activation function (AF1). Current studies of both mechanism of action and small molecule-selective receptor modulators for clinical uses target the structured pocket of the ligand-binding domain to modulate coregulatory protein interactions with the other activation function AF2. However, these approaches overlook AF1 activity. Recent studies have shown that highly flexible intrinsically disordered regions of transcription factors, including that of the N-terminal domain AF1 of NRs, not only are critical for several aspects of NR action but also can be exploited as drug targets, thereby opening unique opportunities for endocrine-based therapies. In this review article, we discuss the role of structural flexibilities in the allosteric modulation of NR activity and future perspectives for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two types of estrogen receptors (ERs) have been identified, the alpha (ERα) and beta (ERβ) receptors [48, 49].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101
RetractedMolecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355 · cited 1×
“Due to available LBD/AF2 crystal structures and the disordered nature of NTD/AF1, rational structure-based design of SRMs has been limited by necessity to how compounds modulate coregulatory protein interactions with AF2 (7), thereby neglecting AF1.”
BackgroundShiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Wright, P. E., & Dyson, H. J. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.003 · Cited by 1,019
Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808 · cited 8×
“The quaternary structure of HNF-4 also indicates how 2 posttranslational modifications (Arg91 methylation and Ser78 phosphorylation) located in a unique position within the interdomain convergence zone can affect the DNA binding activity of the receptor (42).”
BackgroundMethodInfluentialIntrinsic Disorder in Transcription Factors
Liu, J., Perumal, N. B., Oldfield, C. J., Su, E. W., Uversky, V. N., & Dunker, A. K. (2006) · Biochemistry · doi:10.1021/bi0602718 · Cited by 792 · cited 1×
“In fact, most activation domains of transcription factors contain IDRs that have been refractory to crystallization (13, 14).”
BackgroundBerry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767 · cited 1×
“for the tissue-specific effects of the SRMs (30, 58, 59).”
BackgroundMultiple and cooperative trans-activation domains of the human glucocorticoid receptor
Hollenberg, S. M., & Evans, R. M. (1988) · Cell · doi:10.1016/0092-8674(88)90145-6 · Cited by 684
DNA binding site sequence directs glucocorticoid receptor structure and activity
Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R. (2009) · Science · doi:10.1126/science.1164265 · Cited by 673
Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription
Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994) · Science · doi:10.1126/science.8197458 · Cited by 637
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Ko, S.-H., & Kim, H.-S. (2020) · Nutrients · doi:10.3390/nu12010202 · Cited by 516
“There are two types of estrogen receptors: estrogen alpha (ER α) and estrogen beta (ER β) receptors [75].”
BackgroundAllosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors
Levin, E. R., & Hammes, S. R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.122 · Cited by 277
Progesterone Receptor Signaling Mechanisms
Grimm, S. L., Hartig, S. M., & Edwards, D. P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.020 · Cited by 229
Self-citation
Metadata
- Authors
- Simons, S. S., Edwards, D. P., & Kumar, R.
- Affiliations
- National Institutes of Health (US)
- Baylor College of Medicine (US)
- Geisinger College of Health Sciences (US)
- Corresponding author
- Kumar, Raj
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2014-02-01
- Volume
- 28
- Issue
- 2
- Pages
- 173-182
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC3896641
- OpenAlex
- W1967495043
- Cited by
- 88
- References
- 94
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 12 · 2018: 6 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 5
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA046938, R01CA046938)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK049030, R01DK049030)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nuclear receptors, intrinsically disordered regions, N-terminal domain, activation functions, AF-2, ligand-binding domain, allosteric modulation, structural flexibility
- MeSH terms
- Allosteric Regulation, Animals, Humans, Neoplasms, Protein Conformation, Transcriptional Activation, Receptors, Cytoplasmic and Nuclear, Molecular Targeted Therapy, Intrinsically Disordered Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minireview: Dynamic Structures of Nuclear Hormone Receptors: New Promises and Challenges. https://app.cochat.ai/papers/10.1210/me.2013-1334
- The paper
- Simons, S. S., Edwards, D. P., & Kumar, R. (2014). Minireview: Dynamic Structures of Nuclear Hormone Receptors: New Promises and Challenges. Molecular Endocrinology. https://doi.org/10.1210/me.2013-1334
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.